D.E. Shaw & Co
ZLAB icon

D.E. Shaw & Co’s Zai Lab ZLAB Stock Holding History

D.E. Shaw & Co’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-69,000
Closed -$1.67M – 4961
2024
Q3 		$1.67M Hold
69,000
– – ﹤0.01% 2856
2024
Q2 		$1.2M Buy
69,000
+37,000
+116% +$651K ﹤0.01% 3065
2024
Q1 		$513K Buy
+32,000
New +$674K ﹤0.01% 3475
2021
Q4 		– Sell
-2,500
Closed -$263K – 5761
2021
Q3 		$263K Hold
2,500
– – ﹤0.01% 4435
2021
Q2 		$442K Hold
2,500
– – ﹤0.01% 4098
2021
Q1 		$334K Buy
+2,500
New +$387K ﹤0.01% 3667

Other funds holding ZLAB

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

D.E. Shaw & Co's ZLAB Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Zai Lab (ZLAB) stake by 73% in Q1 2026, selling an estimated $3.25M and leaving 63,243 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

D.E. Shaw & Co first reported a position in ZLAB in Q4 2017 and has held it in 29 quarters since. The position peaked at $30.7M in Q4 2020. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • D.E. Shaw & Co held 63,243 shares of Zai Lab worth $1.19M as of Q1 2026.
  • D.E. Shaw & Co sold 175,366 Zai Lab shares in Q1 2026, an estimated $3.25M.
  • Zai Lab made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3316 holding.
  • D.E. Shaw & Co first reported a position in Zai Lab in Q4 2017 and has held it in 29 quarters since.
  • D.E. Shaw & Co's Zai Lab position peaked at $30.7M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.